Viewing nowGlucozen Tablet 500 mg (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Celix Co., Ltd.

MFDS item code 200301345 · Notified 2003.12.22 · Insurance code 646200050
Treatment of type 2 diabetes mellitus
This medication is used for patients with type 2 diabetes who have difficulty controlling blood sugar levels with diet and exercise alone, particularly overweight adult patients. In adults, it can be used alone or in combination with other oral hypoglycemic agents or insulin. It can also be used for children over 10 years old and adolescents in growth either as monotherapy or in combination with insulin. This medication effectively helps control blood sugar levels and improves diabetes management.
The dose should be determined individually based on efficacy and tolerability and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control, this medicine must be initiated at a low dose. Take 500mg per dose, 2–3 times daily, with meals. Increase the dose gradually by 500mg each week. When the dose is increased to 2000mg, it is usually divided into 2 doses, taken in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 doses and take with meals; the maximum daily dose is 2550mg. When initiating treatment and adjusting the dose, measure fasting blood glucose to assess the response to treatment with this medicine and identify the minimum effective dose. Measure blood glycosylated hemoglobin levels approximately every 3 months. The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycosylated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled by diet alone, a short course of this medicine may be sufficient to achieve an adequate effect. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dosage adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, divided into 2 doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this medicine must be discontinued immediately.
Children aged 10 years and older or adolescents who are growing: The usual starting dose is 500 milligrams once daily, taken during or after a meal. Measure blood glucose after 1 week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.
This medication can cause severe lactic acidosis or hypoglycemia; if these symptoms occur, immediately inform medical personnel and discontinue use. It should not be used in patients with moderate or severe renal impairment, dehydration, serious infections, cardiovascular collapse, acute myocardial infarction, sepsis, or other acute conditions. Patients with acute or unstable heart failure, or those undergoing examinations using radiological iodine contrast agents should not be administered this medication. Patients who have had allergic reactions to this medication or other biguanide medications, those with type 1 diabetes, or history of lactic acidosis or ketoacidosis are also excluded from use. Patients with severe infections or severe traumatic systemic disorders should temporarily discontinue this medication until oral intake is restored and renal function returns to normal. If undergoing surgery, this medication should be stopped 48 hours before the procedure and can be resumed after confirming normal renal function post-surgery. This medication is not recommended for patients with liver dysfunction, pneumothorax, severe pulmonary dysfunction, excessive alcohol intake, dehydration, or gastrointestinal disorders. This medication contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. Patients who have irregular meals or insufficient food intake, engage in vigorous exercise, or are taking interacting medications are at risk for lactic acidosis and hypoglycemia and should use the medication cautiously. During treatment with this medication, adverse effects such as gastrointestinal disturbances, metallic taste, skin rashes, anemia, vitamin B12 deficiency, liver dysfunction, or hypoglycemia may occur; if any unusual symptoms arise, consult healthcare personnel. Regularly monitor renal function to prevent the accumulation of this medication and the risk of lactic acidosis, especially in the elderly or those with renal function decline who need to be tested more frequently. Continuously monitor blood sugar control, and if blood sugar is poorly controlled or new symptoms arise during treatment, inform healthcare personnel immediately. Alcohol can interfere with the lactate metabolism of this medication, increasing risks, so it is important to avoid excessive drinking while on this medication. This medication may interact with other hypoglycemic agents or various medications, so when administered together, closely monitor blood sugar and condition according to healthcare personnel's instructions. During pregnancy, this medication crosses the placenta; women who are planning to become pregnant or are pregnant should consult healthcare personnel before use and should not use it if there is a risk of placental insufficiency or preeclampsia. Women who are breastfeeding should carefully decide whether to continue breastfeeding or discontinue medication, as this medication is excreted in breast milk. For children and the elderly, dosages should be adjusted carefully, and renal function should be monitored regularly. In case of overdose, hypoglycemia is rare; however, the medication can accumulate in the body, and treatment such as hemodialysis may be necessary. This medication does not cause weight gain and helps achieve stable blood sugar control and a reduced risk of diabetes complications with long-term use. Keep out of reach of children and do not transfer to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 500mg
Tablet · Prescription medication
Celix Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.